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Background: Chronic treatment with the dietary ﬂavonoid quercetin is known to
lower blood pressure and restore endothelial dysfunction in animal models of hy-
pertension. This study investigated the direct effects of quercetin on vascular
response in chronic 2-kidney, 1-clip (2K1C) renal hypertensive rats. The effects of
antioxidant vitamin ascorbic acid on the vasoreactivity were also examined.
Methods: 2K1C renal hypertension was induced by clipping the left renal artery;
age-matched rats that received sham treatment served as controls. Thoracic aortae
were mounted in tissue baths for the measurement of isometric tension.
Results: Relaxant responses to acetylcholine were signiﬁcantly attenuated in 2K1C
rats in comparison with sham rats. Quercetin or ascorbic acid augmented
acetylcholine-induced relaxation in 2K1C rats, whereas no signiﬁcant differences
were noted in sham rats. The relaxation response to sodium nitroprusside was
comparable between 2K1C and sham rats, and sodium nitroprussideeinduced
relaxation was not altered by quercetin or ascorbic acid in either group. The con-
tractile response to phenylephrine was signiﬁcantly enhanced in 2K1C rats
compared with sham rats. Phenylephrine-induced contraction was inhibited by
pretreatment with quercetin or ascorbic acid in 2K1C rats, whereas neither chemical
affected responses in sham rats. Nw-nitro-L-arginine methyl ester markedly
augmented the contractile response to phenylephrine in sham rats, whereas no
signiﬁcant differences were observed in 2K1C rats. Quercetin or ascorbic acid did
not affect phenylephrine-induced contraction in the presence of Nw-nitro-L-argi-
nine methyl ester in either 2K1C or sham rats.
Conclusion: Acute exposure to quercetin appears to improve endothelium-
dependent relaxation and inhibit the contractile response, similar to the effect of
ascorbic acid in 2K1C hypertension. These results partially explain the vascular
beneﬁcial effects of quercetin in renal hypertension.
Copyright © 2016. The Korean Society of Nephrology. Published by Elsevier. This is
an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).logy, College of Medicine, Chosun University, 309, Pilmundaero, Dong-gu, Gwangju 501-759, Korea.
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Hypertension, a typical risk factor of cardiovascular disease,
involves endothelial dysfunction in large conduit and small
resistance arteries [1]. Indeed, impaired endothelium-
dependent vasodilation was observed in a number of experi-
mental models of hypertension, including 2-kidney, 1-clip
(2K1C) renal hypertension [2e4]. The biological activity of ni-
tric oxide (NO), an effective endothelium-derived relaxing
factor, is primarily associated with endothelial NO synthase
activity or its interaction with the superoxide anion, which is
produced in the vascular wall by free radicalegenerating en-
zymes [5]. Endothelium-derived NO may be scavenged by the
superoxide anion, causing reduced bioavailability of NO and
diminishing vasorelaxation [6]. It is now well established that
endothelial dysfunction in hypertension is partially linked to
the exaggerated production of superoxide anions [7,8] and that
oxidative stress is responsible for impaired endothelial modu-
lation in 2K1C hypertension [9,10]. Therefore, antioxidants may
exert beneﬁcial effects on the vascular complications associated
with hypertension.
Quercetin is a commonly found ﬂavonol-type ﬂavonoid that
is widely distributed in dietary vegetables, fruits, and wine [11].
Previous studies have demonstrated that the ﬂavonoid quer-
cetin has various physiological effects including antioxidant
and antihypertensive effects as well as those associated with
improvements in vascular reactivity [12,13]. The vascular
beneﬁcial effects induced by quercetin are mainly due to its
antioxidant properties, which might interact with the
endothelium-derived NO system [14]. Accumulated evidence
demonstrates that ﬂavonoids increase the biological activity of
NO by interacting with superoxide anions [15], and chronic oral
treatment with quercetin in experimental hypertension was
shown to protect against impairments in vascular endothelial
function [16]. Apart from the chronic effects of ﬂavonoids
associated with endothelial dysfunction in hypertension, acute
exposure to quercetin in vitro restores endothelium-dependent
relaxation and inhibits the contractile responses to the agonist
in genetically hypertensive rats [11,17]. For this point of view,
although it has been demonstrated that chronic treatment with
quercetin exerts antihypertensive and antioxidant effects and
improves endothelial function in renovascular hyperten-
sion [18], the acute effects of quercetin on vascular function in
renal hypertension remain unclear.
The present study aimed to examine the direct effects of
quercetin on vascular reactivity in chronic 2K1C hypertensive
rats. The effects of quercetin on endothelium-dependent or
endothelium-independent relaxation in response to acetyl-
choline or sodium nitroprusside (SNP) and the contractile re-
sponses to the a1-adrenergic agonist phenylephrine were
investigated in isolated aortae from 2K1C hypertensive and
sham-clipped control rats. The effects of the antioxidant
vitamin ascorbic acid (vitamin C) on vascular reactivity were
also examined.
Methods
Induction of 2K1C renal hypertension
Male Sprague-Dawley rats (Samtaco Inc., Osan, Korea),
weighing 160e180 g, were anesthetized with intraperitoneal
injection of sodium thiopental (40 mg/kg). Under antisepticconditions, the left posterior side of the animal was shaved and
sterilized with 70% ethanol. An incision was made on the left
ﬂank to provide access to the left renal artery, which was
separated from the renal vein and cleaned of connective tissue.
A silver clip with an internal diameter of 0.2mmwas applied on
the exposed renal artery. The clip was then turned so that the
slit opening faces the abdomen, resulting in partial occlusion of
renal perfusion. The contralateral kidney was not disturbed.
The muscles and skin were sutured immediately, and the rats
were allowed to recover from anesthesia. Control rats received
a sham treatment: they underwent the same surgical proce-
dure as 2K1C rats, except for clip placement. All rats were
maintained on standard chow with free access to drinking
water. They were killed for examination at 10 weeks after
clipping because endothelial dysfunction is associated with the
duration of hypertension [19]. Hypertensive rats were selected
by measuring systolic blood pressure in the conscious state
using the tail cuff method; they were considered hypertensive
when the systolic pressure was over 160 mmHg.
Tissue preparation
At the time of experimentation, the descending thoracic
aorta between the aortic arch and diaphragm was excised
through a ventral incision and placed in cold, standard physi-
ological salt solution of the following composition (in mM):
NaCl 118.3, KCl 4.7, NaHCO3 25.0, MgCl2 1.2, KH2PO4 1.2, CaCl2
2.5, and glucose 11.1. Vessels were cleaned of adherent fat and
connective tissues and sectioned into cylindrical rings (2e3mm
in width) under a dissecting microscope. Care was taken not to
stretch the artery or dislodge the vascular endothelium.
The aortic rings were mounted between two triangle-sha-
ped stainless steel holders in the vessel lumen in organ
chambers containing 15 mL of physiological salt solution
maintained at 37 ± 0.05C, aerated with a mixture of 95% ox-
ygen and 5% carbon dioxide to maintain a pH of 7.4 ± 0.01
throughout the experiment. One of the holders was ﬁxed at the
bottom of the chambers and the other was connected to a force
displacement transducer (Grass FTO3, Quincy, Mass, USA) to
measure isometric tension development. Before initiating
speciﬁc experimental protocols, aortic rings were stretched to
the point of their optimal lengthetension relationship at 2 g,
determined in similar preliminary experiments using repeated
exposure to 60mM KCl solution (obtained by equimolar
replacement of NaCl by KCl in the physiological solution), and
allowed to equilibrate for a period of at least 90minutes. During
this period of stabilization, the bath solution was replaced
every 15 minutes. After an equilibration period, aortic rings
were stimulated with 60mM KCl to test their functional
viability. All experimental procedures were performed in the
presence of indomethacin (10e5M).
Protocols
Endothelium-dependent and endothelium-independent
relaxation in response to acetylcholine and SNPwere examined
using aortic rings from 2K1C and sham-operated rats under
submaximally precontracted with phenylephrine (2  10e7M
in sham and 3  10e8M in 2K1C), based on doses obtained in
preliminary experiments. The responses of the aortic rings to
the cumulative addition of acetylcholine (from 10e9 to 10e5M)
and SNP (from 10e10 to 10e6.5M) were examined in parallel
Figure 1. Relaxant responses to acetylcholine in phenylephrine-
precontracted aortic rings from 2K1C hypertensive and sham-clipped
control rats. Points represent means ± SEs for 6e8 experiments.
*P < 0.05, compared with sham values.
2K1C, 2-kidney, 1-clip; SE, standard error.
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(10e5M) [11,17] or ascorbic acid (10e5M) 20 minutes before the
addition of phenylephrine.
In another set of experiments, aortic rings from 2K1C and
sham rats were pretreated with the vehicle, quercetin (10e5M)
or ascorbic acid (10e5M) for 20 minutes; then, the contractile
responses to the cumulative addition of phenylephrine (from
10e9 to 10e5M) were recorded. The experiments were repeated
in the presence and absence of the NO synthase inhibitor Nw-
nitro-L-arginine methyl ester (L-NAME, 10e4M).
Drugs and chemicals
The drugs used in this study comprised acetylcholine,
ascorbic acid, indomethacin, L-NAME, phenylephrine, quer-
cetin, and SNP. They were purchased from Sigma Chemical Co.
(St. Louis, MO, USA). All other chemicals were of reagent grade.
Indomethacin and quercetin were dissolved in dimethylsulf-
oxide, while the others were prepared in distilled water. Final
bath concentrations of dimethylsulfoxide were less than 0.05%,
which did not alter the contraction or relaxation responses.
Statistical analysis
Values presented in the ﬁgures are expressed as the means
and standard errors of the means for the number of rats or
tissues indicated in legends. The relaxant responses are given as
the percent change in phenylephrine-induced contractile ten-
sion; the contractile responses are expressed as a percentage of
the contraction developed by exposure to 60mM KCl. Statistical
comparisons were performed by Student's t test or analysis of
variance with repeated measurements and Fisher's post hoc
test. Differences were considered statistically signiﬁcant when
P < 0.05.
Results
The systolic blood pressures were signiﬁcantly increased at
2 weeks after surgery in 2K1C hypertensive rats as compared
with sham-clipped control rats (Table 1). The magnitude of KCl
(60mM)einduced isometric tension development was com-
parable between the two groups (1.45 ± 0.12 g in control; 1.52 ±
0.14 g in 2K1C).
The relaxant response to acetylcholine in the aortic rings
precontracted with phenylephrine was signiﬁcantly attenuated
in 2K1C rats as compared with sham rats (Fig. 1). Treatment
with L-NAME (10e4M) completely blocked the acetylcholine-
induced relaxation in the 2K1C and sham groups (data not
shown). In aortic rings from 2K1C rats, impaired vasodilatory
response to acetylcholine was improved by preincubation with
quercetin or ascorbic acid. However, both chemicals did notTable 1. Changes in systolic blood pressure (mmHg) during 10 weeks in
0 2 4
Sham (n ¼ 43) 132 (3.7) 137 (3.2) 136 (
2K1C (n ¼ 42) 134 (3.9) 148 (3.4)* 175 (
Results are means (SEs) for n experiments.
*P < 0.05, compared with sham values.
2K1C, 2-kidney, 1-clip; SE, standard error.affect the relaxant response to acetylcholine in sham rats
(Fig. 2). The relaxant response to SNP was not altered in 2K1C
rats (Fig. 3). Quercetin or ascorbic acid did not affect the SNP-
induced relaxation in either 2K1C or sham rats (Fig. 4).
The contractile response to phenylephrine was signiﬁcantly
enhanced in aortic rings from 2K1C rats as compared with those
from sham rats (Fig. 5). Phenylephrine-induced contraction was
inhibited by pretreatment with quercetin or ascorbic acid in
2K1C rats, whereas neither compounds affected the contractile
response to phenylephrine in sham rats (Fig. 6). L-NAME
markedly augmented the contractile response to phenylephrine
in aortic rings from sham rats, whereas no signiﬁcant differences
were noted in 2K1C rats. In the presence of L-NAME, neither
quercetin nor ascorbic acid affected phenylephrine-induced
contraction in either 2K1C or sham rats (Fig. 7). Quercetin or
ascorbic acid did not affect L-NAME aloneeinduced vascular
response.
Discussion
Dysfunctional endothelial modulation is commonly charac-
terized by an alteration in the vasodilatory capacity of the
vascular endothelium and plays a pivotal role in the patho-
physiology of hypertension [20]. In the present study,
endothelium-dependent relaxation in response to acetylcholinesham-clipped and 2K1C rats
Weeks
6 8 10
3.3) 134 (3.0) 136 (3.9) 135 (3.0)




Figure 2. Effects of quercetin or ascorbic acid on acetylcholine-induced
relaxations. The aortic rings used were from sham-clipped control (A) and
2K1C hypertensive rats (B). Points represent means ± SEs for 6e8 experi-
ments.
*,✝P < 0.05, compared with corresponding control values.
2K1C, 2-kidney, 1-clip; SE, standard error.
Figure 3. Relaxant responses to SNP in phenylephrine-precontracted
aortic rings from 2K1C hypertensive and sham-clipped control rats.
Points represent means ± SEs for 6e8 experiments.
2K1C, 2-kidney, 1-clip; SE, standard error; SNP, sodium nitroprusside.
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compared with that in sham-clipped control rats. Similar results
were also demonstrated recently in our previous report [21]. The
acetylcholine-induced vasodilatory effects were completely
abolished in both 2K1C and sham rats by treatment with L-
NAME, which is an NO synthase inhibitor, suggesting that
acetylcholine-induced vasorelaxation mainly contributes to NO
synthaseederived NO. As observed previously in genetically
hypertensive rats [17], in this study, endothelium-dependent
relaxation in response to acetylcholine was augmented by pre-
incubationwith quercetin or ascorbic acid in 2K1C rats, whereas
the two chemicals did not affect the relaxant response to
acetylcholine in sham rats. These results indicate that
endothelium-derived NO-mediated relaxation responses
induced by acetylcholine are promoted by quercetin and
ascorbic acid in 2K1C hypertensive aortae, and such mecha-
nisms are absent in normotensive tissues. In association withthese observations, previous studies [22,23] have proposed that
an excessive production of endothelium-derived factors such as
vasoconstrictor prostanoids or superoxide anions may take part
in blunted acetylcholine-induced vasorelaxation in hypertensive
arteries. However, the participation of vasoconstrictor prosta-
noids in acetylcholine-induced relaxation may be ruled out in
2K1C rats in this study because all the experimental procedures
were performed in the presence of indomethacin, a cyclo-
oxygenase inhibitor. Therefore, superoxide anions may be a
possible candidate responsible for impairments in endothelium-
dependent relaxation in hypertensive aortae. It may be postu-
lated that the impaired relaxation in response to acetylcholine
observed in the 2K1C aortae is caused by the harmful effects of
superoxide anions on endothelium-derived NO. It has been
demonstrated that NO can be scavenged by superoxide anions to
form peroxynitrite (ONOOe) [24], thus reducing the bioavail-
ability of endothelium-derivedNO. Taken together, as previously
observed in genetic hypertension [17], the enhanced
acetylcholine-induced relaxation in 2K1C rats may be linked to
superoxide anion scavenging properties by ﬂavonoid quercetin
or antioxidant vitamin.
The present study conﬁrmed the earlier observation
[21] that endothelium-independent relaxation in response to
SNP, which is an NO donor, is comparable between aortic rings
from 2K1C and sham rats. Quercetin or ascorbic acid did not
affect SNP-induced relaxation in either 2K1C or sham rats,
suggesting that NO-mediated vascular relaxation in hyperten-
sive and normotensive rats is not altered by quercetin or
ascorbic acid. It has been reported that ﬂavonoids primarily
exert their beneﬁcial vascular effects by accumulating on the
surfaces between endothelial and vascular smooth muscle cells
and improving NO bioavailability by either enhancing
endothelium-derived NO production or inhibiting its destruc-
tion by free radicals [15]. Thus, it may be hypothesized that the
effects of quercetin or ascorbic acid are masked on which SNP
induced fully NO-mediated vasorelaxation, as shown previ-




Figure 4. Effects of quercetin or ascorbic acid on SNP-induced re-
laxations. The aortic rings used were from sham-clipped control (A) and
2K1C hypertensive rats (B). Points represent means ± SEs for 6e8 experi-
ments.
2K1C, 2-kidney, 1-clip; SE, standard error; SNP, sodium nitroprusside.
–
Figure 5. Contractile responses to phenylephrine in aortic rings from
2K1C hypertensive and sham-clipped control rats. Points represent
means ± SEs for 6e8 experiments.
*P < 0.05, compared with sham values.
2K1C, 2-kidney, 1-clip; SE, standard error.
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contractile agonist is enhanced in disease states such as hy-
pertension [25]. In accordancewith our previous ﬁndings [26],
the contractile response to phenylephrine was augmented in
the aortic rings from 2K1C hypertensive rats as compared with
those from sham-clipped control rats. In the present study,
quercetin and ascorbic acid inhibited phenylephrine-induced
contraction in the aortic rings from 2K1C rats, whereas these
compounds had no effect on the aortic rings from sham rats.
These results led us to hypothesize that improved biological
activity of endothelium-derived NO may be responsible for
reduction in phenylephrine-induced contraction by quercetin
or ascorbic acid in 2K1C rats. To investigate this issue, the
effects of quercetin or ascorbic acid on the contractile
response to phenylephrine were examined in the presence of
L-NAME. The contractile response to phenylephrine was
markedly enhanced by L-NAME treatment in sham rats,
whereas phenylephrine-induced contraction was comparablein 2K1C rats, suggesting that the role of endothelium-derived
NO is impaired in hypertensive rats. Similar results were also
found in our previous study [26], i.e., endothelium removal
enhanced phenylephrine-induced contraction in 2K1C aortae,
whereas it had no effect in sham tissues. These results imply
that the endothelium may modulate not only vasorelaxation
but also vascular contraction induced by vasoconstrictor
agents. It has been reported that such vasoconstrictors
interact with the endothelium to cause the release of vaso-
relaxation factors, which then have an inhibitory effect on
vascular smooth muscle tone [3]. As expected, quercetin and
ascorbic acid did not affect phenylephrine-induced contrac-
tion in the presence of L-NAME in either 2K1C or sham rats.
The results strongly suggest that the reduction of the con-
tractile response to phenylephrine in hypertensive rats by
quercetin or ascorbic acid is due to alterations in the biological
activity of endothelium-derived NO. On the other hand, our
results are inconsistent with a previous study by Ajay et al
[17], who observed that the magnitude of phenylephrine-
induced contraction was similar between spontaneous hy-
pertensive and normotensive Wistar rats, and the inhibitory
effects of quercetin and ascorbic acid on the contractile
response to phenylephrine in hypertensive rats were reversed
in the presence of L-NAME. They also reported that the
inhibitory effect of quercetin on phenylephrine-induced
contraction in hypertensive aortae is more potent than that
of ascorbic acid. These differences possibly arise from complex
underlying mechanisms; a possible reason for this discrep-
ancy may be differences in the method of induction of
experimental hypertension, animal species, or the experi-
mental methods used [25].
In the present study, the effects of the ﬂavonoid quercetin on
vascular function resembled those of the antioxidant vitamin
ascorbic acid, suggesting that the quercetin-induced improved
vascular reactivity in 2K1C hypertensive rats may be attributed
to the antioxidant effect of the ﬂavonoid. To our knowledge,
Figure 7. Effects of L-NAME on phenylephrine-induced contractions.
The aortic rings used were from sham-clipped control (A) and 2K1C hy-
pertensive rats (B). Effects of quercetin or ascorbic acid on phenylephrine-
induced contractions in the presence of L-NAME are also shown. Points
represent means ± SEs for 6e8 experiments.
*P < 0.05, compared with corresponding control values.






Figure 6. Effects of quercetin or ascorbic acid on phenylephrine-
induced contractions. The aortic rings used were from sham-clipped
control (A) and 2K1C hypertensive rats (B). Points represent means ± SEs
for 6e8 experiments.
*,✝P < 0.05, compared with corresponding control values.
2K1C, 2-kidney, 1-clip; SE, standard error.
Kidney Res Clin Pract 35 (2016) 15e2120this is the ﬁrst report to show that acute exposure to quercetin
or ascorbic acid promotes endothelium-dependent relaxation
and inhibits contractile responses in 2K1C rats. In addition, the
enhanced acetylcholine-induced relaxation and diminished
phenylephrine-induced contraction caused by quercetin or
ascorbic acid in hypertensive rats are associated with alter-
ations in the biological activity of endothelium-derived NO.
Previous studies [27,28] have demonstrated elevated superox-
ide anion levels in renovascular hypertensive rats. Accumu-
lating evidence suggests that maintenance of 2K1C
hypertension involves a systemic increase in oxidative stress
[9,10]; furthermore, we recently reported that vascular oxida-
tive stress might be involved in chronic 2K1C renal hyperten-
sion [29]. Therefore, as discussed previously, the possibility that
the improved vascular reactivity by quercetin in 2K1C hyper-
tensive rats may be linked, at least in part, to the ﬂavonoid's
protective effects via a biological interaction between vascular
endothelium-derived NO and superoxide anions cannot be
ruled out; conﬁrmation of this theory would require the directmeasurement of NO and superoxide anion levels, which we
were unable to perform in this study.
In summary, acute exposure to quercetin improves
endothelium-dependent relaxation and inhibits a1-adreno-
ceptoremediated contractions in aortic rings from 2K1C hy-
pertensive rats, similar to the effects of the antioxidant vitamin
ascorbic acid. The effects of quercetin may be linked, at least in
part, to its protective effects via the biological actions of
vascular endothelial NO in chronic renal hypertension.
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